{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:16:46Z","timestamp":1782742606575,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MSD Spain, Spain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardiovascular disease is a major cause of morbidity in an aging HIV population. However, risk estimation with the most frequent equations usually classifies HIV patients as having a low or moderate risk. Several studies have described a very high prevalence of subclinical atherosclerosis in a middle-aged, non-HIV population. There is insufficient body of knowledge to understand if this is the case in people living with HIV (PLWH). We aim to calculate the proportion of patients with subclinical atherosclerosis in a single site cohort of HIV-infected subjects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We have analyzed chronically HIV infected adults (\u2265\u200918\u00a0years) who were on active follow-up in an HIV unit specialized in the care of cardiovascular health. The most recent clinical visit and vascular ultrasonography were used to assess the objectives of our research. Our primary objective was to describe the proportion of participants with subclinical atherosclerosis (focal protrusion into the lumen\u2009&gt;\u20090.5\u00a0mm or\u2009&gt;\u200950% of the surrounding IMT or a diffuse thickness\u2009&gt;\u20091.5\u00a0mm) in a single site cohort of PLWH. Carotid and iliofemoral territories were evaluated. As a secondary objective we have run a multivariate analysis to determine which HIV and non-HIV factors might be related with the presence of atherosclerotic plaques.<\/jats:p>\n                <jats:p><jats:bold>Findings<\/jats:bold><\/jats:p>\n                <jats:p>We included a total of 463 participants between November 2017 to October 2019. Subjects were predominantly male (84.2%) with a mean age of 48.8\u00a0years (SD 10.7). Hypercholesterolemia (36%) was the most prevalent comorbidity followed by Hypertension (18%) and Hypertriglyceridemia (16%). Mean duration of HIV infection is 12.3\u00a0years. Overall, participants had been receiving cART for a median of 9.5\u00a0years. Subclinical atherosclerosis was found in 197 subjects (42.5%; CI 95% [38.0\u201347.2]). The disease was found more frequently in the femoral arteries (37.8%) than in the carotid vascular bed (18.6%). Despite some HIV factors correlated with the presence of plaques in a univariate analysis (e.g., time with HIV-1 RNA\u2009&gt;\u200950 copies\/mL or time from HIV diagnosis), the only two explanatory factors that remained associated with the presence of atherosclerotic plaques in the multivariate analysis were smoking (OR 5.47, 95% CI 3.36 \u2013 8.90) and age (OR 1.13, 95%CI 1.10 \u2013 1.16).<\/jats:p>\n                <jats:p><jats:bold>Interpretation<\/jats:bold><\/jats:p>\n                <jats:p>We have found a very high prevalence of subclinical atherosclerosis among our cohort of PLWH. Despite having analyzed several HIV factors, age and smoking have been found to be the only factors associated with the development of atherosclerotic plaques.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09850-8","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T11:02:33Z","timestamp":1725879753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Subclinical atherosclerosis burden in carotid and femoral territories in HIV subjects: relationships with HIV and non-HIV related factors"],"prefix":"10.1186","volume":"24","author":[{"given":"Pedro","family":"Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncal","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Sagastagoitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Cotarelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo P\u00e9rez","family":"de Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"9850_CR1","doi-asserted-by":"publisher","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853\u201360. https:\/\/doi.org\/10.1056\/NEJM199803263381301.","DOI":"10.1056\/NEJM199803263381301"},{"key":"9850_CR2","doi-asserted-by":"crossref","unstructured":"Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8(12):e81355. Available at: \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24367482.","DOI":"10.1371\/journal.pone.0081355"},{"key":"9850_CR3","doi-asserted-by":"publisher","unstructured":"Autenrieth CS, Beck EJ, Stelzle D, Mallouris C, Mahy M, Ghys P. Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020. PLoS One. 2018;13(11):e0207005. https:\/\/doi.org\/10.1371\/journal.pone.0207005.","DOI":"10.1371\/journal.pone.0207005"},{"key":"9850_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/COH.0000000000000298","volume":"11","author":"G Wandeler","year":"2016","unstructured":"Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population. Curr Opin HIV AIDS. 2016;11:492\u2013500.","journal-title":"Curr Opin HIV AIDS"},{"key":"9850_CR5","doi-asserted-by":"crossref","unstructured":"Vance DE, Mugavero M, Willig J, Raper JL, Saag MS.. Aging With HIV: A Cross-Sectional Study of Comorbidity Prevalence and Clinical Characteristics Across Decades of Life. J Assoc Nurses AIDS Care.\u00a02011;22(1):17\u201325.","DOI":"10.1016\/j.jana.2010.04.002"},{"key":"9850_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120\u20136. https:\/\/doi.org\/10.1093\/cid\/cir627.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"9850_CR7","doi-asserted-by":"publisher","first-page":"e0195443","DOI":"10.1371\/journal.pone.0195443","volume":"13","author":"UE Ekrikpo","year":"2018","unstructured":"Ekrikpo UE, Kengne AP, Bello AK, et al. Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis. PLoS One. 2018;13(4):e0195443. https:\/\/doi.org\/10.1371\/journal.pone.0195443.","journal-title":"PLoS ONE"},{"issue":"1","key":"9850_CR8","doi-asserted-by":"publisher","first-page":"e041734","DOI":"10.1136\/bmjopen-2020-041734","volume":"11","author":"NGA Nanditha","year":"2021","unstructured":"Nanditha NGA, Paiero A, Tafessu HM, et al. Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study. BMJ Open. 2021;11(1):e041734. https:\/\/doi.org\/10.1136\/bmjopen-2020-041734.","journal-title":"BMJ Open"},{"issue":"7","key":"9850_CR9","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1016\/S2352-3018(20)30107-7","volume":"7","author":"A Winston","year":"2020","unstructured":"Winston A, Spudich S. Cognitive disorders in people living with HIV. Lancet HIV. 2020;7(7):e504\u201313. https:\/\/doi.org\/10.1016\/S2352-3018(20)30107-7. PMID: 32621876.","journal-title":"Lancet HIV"},{"issue":"14","key":"9850_CR10","doi-asserted-by":"publisher","first-page":"e012241","DOI":"10.1161\/JAHA.119.012241","volume":"8","author":"A Alonso","year":"2019","unstructured":"Alonso A, Barnes AE, Guest JL, et al. HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database. J Am Heart Assoc. 2019;8(14):e012241. https:\/\/doi.org\/10.1161\/JAHA.119.012241.","journal-title":"J Am Heart Assoc"},{"key":"9850_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","volume":"13","author":"FM Islam","year":"2012","unstructured":"Islam FM, Wu J, Jannson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13:453\u201368.","journal-title":"HIV Med"},{"key":"9850_CR12","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","volume":"92","author":"VA Triant","year":"2007","unstructured":"Triant VA, Lee H, Hadigan C, Grinspoon K. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"9850_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","volume":"13","author":"FM Islam","year":"2012","unstructured":"Islam FM, Wu J, Jannson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13:453\u201368.","journal-title":"HIV Med"},{"key":"9850_CR14","first-page":"119","volume":"13","author":"F Fedele","year":"2011","unstructured":"Fedele F, Bruno N, Mancone M. Cardiovascular risk factors and HIV disease. AIDS Rev. 2011;13:119\u201329.","journal-title":"AIDS Rev"},{"issue":"9","key":"9850_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044454","volume":"7","author":"DA Duprez","year":"2012","unstructured":"Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One. 2012;7(9): e44454. https:\/\/doi.org\/10.1371\/journal.pone.0044454.","journal-title":"PLoS ONE"},{"key":"9850_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365\u201371.","journal-title":"Nat Med"},{"issue":"4","key":"9850_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1189\/jlb.0809580","volume":"87","author":"SM Crowe","year":"2010","unstructured":"Crowe SM, Westhorpe CL, Mukhamedova N, et al. The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol. 2010;87(4):589\u201398. https:\/\/doi.org\/10.1189\/jlb.0809580.","journal-title":"J Leukoc Biol"},{"issue":"24","key":"9850_CR18","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.114.014310","volume":"131","author":"L Fern\u00e1ndez-Friera","year":"2015","unstructured":"Fern\u00e1ndez-Friera L, Pe\u00f1alvo JL, Fern\u00e1ndez-Ortiz A, et al. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131(24):2104\u201313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.014310. Epub 2015 Apr 16 PMID: 25882487.","journal-title":"Circulation"},{"issue":"11","key":"9850_CR19","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jacc.2015.12.056","volume":"67","author":"M Laclaustra","year":"2016","unstructured":"Laclaustra M, Casasnovas JA, Fern\u00e1ndez-Ortiz A, et al. Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium: the AWHS study. J Am Coll Cardiol. 2016;67(11):1263\u201374. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.056.","journal-title":"J Am Coll Cardiol"},{"key":"9850_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"ESC\/EAS guidelines for the management of dyslipidaemias","year":"2020","unstructured":"ESC\/EAS guidelines for the management of dyslipidaemias. lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111\u201388.","journal-title":"Eur Heart J."},{"key":"9850_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","volume":"27","author":"JP Tate","year":"2013","unstructured":"Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27:563\u201372.","journal-title":"AIDS"},{"issue":"14","key":"9850_CR22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0025-7753(03)74007-X","volume":"121","author":"R Ramos","year":"2003","unstructured":"Ramos R, Solanas P, Cord\u00f3n F, et al. Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions. Med Clin (Barc). 2003;121(14):521\u20136 article in Spanish.","journal-title":"Med Clin (Barc)"},{"issue":"11","key":"9850_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.118.036211","volume":"138","author":"PY Hsue","year":"2018","unstructured":"Hsue PY, Waters DD. Time to recognize HIV infection as a major cardiovascular risk factor. Circulation. 2018;138(11):1113\u20135. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036211.","journal-title":"Circulation"},{"key":"9850_CR24","doi-asserted-by":"publisher","unstructured":"Henry K, Melroe H, Huebsch J, Hermundson J, Levine C, Swensen L, Daley J. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998 May 2;351(9112):1328. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(05)79053-X.","DOI":"10.1016\/S0140-6736(05)79053-X"},{"issue":"7","key":"9850_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/hiv.13093","volume":"22","author":"M Saumoy","year":"2021","unstructured":"Saumoy M, Di Yacovo S, P\u00e9rez S, et al. Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations. HIV Med. 2021;22(7):581\u201391. https:\/\/doi.org\/10.1111\/hiv.13093.","journal-title":"HIV Med"},{"issue":"10","key":"9850_CR26","doi-asserted-by":"publisher","first-page":"e2018099","DOI":"10.1001\/jamanetworkopen.2020.18099","volume":"3","author":"MM McLaughlin","year":"2020","unstructured":"McLaughlin MM, Ma Y, Scherzer R, et al. Association of viral persistence and atherosclerosis in adults with treated HIV infection. JAMA Netw Open. 2020;3(10):e2018099. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.18099.","journal-title":"JAMA Netw Open"},{"key":"9850_CR27","doi-asserted-by":"publisher","unstructured":"Calza L, Borderi M, Colangeli V, et al. No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide\/emtricitabine plus raltegravir, dolutegravir or elvitegravir\/cobicistat during a two-year follow-up. Infect Dis (Lond). 2020;52(4):249\u201356. https:\/\/doi.org\/10.1080\/23744235.2019.1707279.","DOI":"10.1080\/23744235.2019.1707279"},{"issue":"2","key":"9850_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/cid\/ciw261","volume":"63","author":"DB Hanna","year":"2016","unstructured":"Hanna DB, Guo M, B\u016f\u017ekov\u00e1 P, et al. HIV infection and carotid artery intima-media thickness: pooled analyses across 5 cohorts of the NHLBI HIV-CVD Collaborative. Clin Infect Dis. 2016;63(2):249\u201356. https:\/\/doi.org\/10.1093\/cid\/ciw261.","journal-title":"Clin Infect Dis"},{"issue":"22","key":"9850_CR29","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1136\/hrt.2009.177774","volume":"95","author":"E Hulten","year":"2009","unstructured":"Hulten E, Mitchell J, Scally J, Gibbs B, Villines TC. HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies. Heart. 2009;95(22):1826\u201335. https:\/\/doi.org\/10.1136\/hrt.2009.177774.","journal-title":"Heart"},{"issue":"1","key":"9850_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12879-022-07976-1","volume":"23","author":"J Fern\u00e1ndez Soto","year":"2023","unstructured":"Fern\u00e1ndez Soto J, Romero-Jim\u00e9nez MJ, Alarc\u00f3n Garc\u00eda JC, Bonet Estruch E, S\u00e1nchez Ramos JL, Casta\u00f1o L\u00f3pez M\u00c1. Predictors of subclinical atherosclerosis in HIV. BMC Infect Dis. 2023;23(1):17. https:\/\/doi.org\/10.1186\/s12879-022-07976-1.","journal-title":"BMC Infect Dis"},{"key":"9850_CR31","doi-asserted-by":"publisher","unstructured":"Protogerou AD, Fransen J, Zampeli E, Argyris AA, Aissopou E, Arida A, Konstantonis GD, Tentolouris N, Makrilakis K, Psichogiou M, Daikos G, Kitas GD, Sfikakis PP. The additive value of femoral ultrasound for subclinical atherosclerosis assessment in a single center cohort of 962 adults, including high risk patients with rheumatoid arthritis, human immunodeficiency virus infection and type 2 diabetes mellitus. PLoS One. 2015;10(7):e0132307. https:\/\/doi.org\/10.1371\/journal.pone.0132307.","DOI":"10.1371\/journal.pone.0132307"},{"issue":"7","key":"9850_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.7326\/M13-1754","volume":"160","author":"WS Post","year":"2014","unstructured":"Post WS, Budoff M, Kingsley L, Palella FJ Jr, Witt MD, Li X, George RT, Brown TT, Jacobson LP. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014;160(7):458\u201367. https:\/\/doi.org\/10.7326\/M13-1754.","journal-title":"Ann Intern Med"},{"issue":"19","key":"9850_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019291","volume":"10","author":"C Soares","year":"2021","unstructured":"Soares C, Samara A, Yuyun MF, Echouffo-Tcheugui JB, Masri A, Samara A, Morrison AR, Lin N, Wu WC, Erqou S. Coronary artery calcification and plaque characteristics in people living with hiv: a systematic review and meta-analysis. J Am Heart Assoc. 2021;10(19): e019291. https:\/\/doi.org\/10.1161\/JAHA.120.019291.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"9850_CR34","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.jacc.2020.02.026","volume":"75","author":"B Lopez-Melgar","year":"2020","unstructured":"Lopez-Melgar B, Fern\u00e1ndez-Friera L, Oliva B, et al. Short-term progression of multiterritorial subclinical atherosclerosis. J Am Coll Cardiol. 2020;75(14):1617\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"9850_CR35","doi-asserted-by":"publisher","unstructured":"Shaikh K, Bhondoekhan F, Haberlen S, Nakanishi R, Roy SK, Alla VM, Brown TT, Lee J, Osawa K, Almeida S, Rahmani S, Nezarat N, Sheidaee N, Kim M, Jayawardena E, Kim N, Hathiramani N, Palella FJ, Witt M, Ahmad K, Kingsley L, Post WS, Budoff MJ. Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection. AIDS. 2022;36(2):215\u201324. https:\/\/doi.org\/10.1097\/QAD.0000000000003093.","DOI":"10.1097\/QAD.0000000000003093"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09850-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09850-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09850-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T02:02:33Z","timestamp":1726020153000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09850-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9850"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09850-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was evaluated and approved by the local Ethics Committee of Hospital Cl\u00ednico San Carlos in Madrid with the code 17\/235-E_EPAOD. The project was conducted according to the principles of Declaration of Helsinki for medical research. Informed consent was obtained from all persons participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"932"}}